These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33236337)

  • 41. Long-term outcomes of intravesical dimethyl sulfoxide/heparin/hydrocortisone therapy for interstitial cystitis/bladder pain syndrome.
    Lim YN; Dwyer P; Murray C; Karmakar D; Rosamilia A; Thomas E
    Int Urogynecol J; 2017 Jul; 28(7):1085-1089. PubMed ID: 27987022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of Intratrigonal Botulinum Toxin in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Long-Term, Single-Center Study in Real-Life Conditions.
    Abreu-Mendes P; Ferrão-Mendes A; Botelho F; Cruz F; Pinto R
    Toxins (Basel); 2022 Nov; 14(11):. PubMed ID: 36356025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of cystoscopy and hydrodistention on symptoms and bladder capacity in interstitial cystitis/bladder pain syndrome.
    Kirk PS; Santiago-Lastra Y; Qin Y; Stoffel JT; Clemens JQ; Cameron AP
    Neurourol Urodyn; 2018 Aug; 37(6):2002-2007. PubMed ID: 29566264
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Liposomal bladder instillations for IC/BPS: an open-label clinical evaluation.
    Peters KM; Hasenau D; Killinger KA; Chancellor MB; Anthony M; Kaufman J
    Int Urol Nephrol; 2014 Dec; 46(12):2291-5. PubMed ID: 25209396
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome.
    Kuo HC; Chancellor MB
    BJU Int; 2009 Sep; 104(5):657-61. PubMed ID: 19338543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Using Botulinum Toxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome-Possible Pathomechanisms and Practical Issues.
    Jhang JF
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31689912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety comparison of pharmacotherapies for interstitial cystitis and bladder pain syndrome: a systematic review and Bayesian network meta-analysis.
    Di XP; Luo DY; Jin X; Zhao WY; Li H; Wang KJ
    Int Urogynecol J; 2021 May; 32(5):1129-1141. PubMed ID: 33638677
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis.
    Gülpınar Ö; Esen B; Kayış A; Gökçe Mİ; Süer E
    Neurourol Urodyn; 2018 Jan; 37(1):257-262. PubMed ID: 28480984
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravesical treatment of bladder pain syndrome/interstitial cystitis: from the conventional regimens to the novel botulinum toxin injections.
    Dellis A; Papatsoris AG
    Expert Opin Investig Drugs; 2014 Jun; 23(6):751-7. PubMed ID: 24749738
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complete response to acupuncture therapy in female patients with refractory interstitial cystitis/bladder pain syndrome.
    Sönmez MG; Kozanhan B
    Ginekol Pol; 2017; 88(2):61-67. PubMed ID: 28326514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.
    Nickel JC; Egerdie B; Davis E; Evans R; Mackenzie L; Shrewsbury SB
    J Urol; 2016 Sep; 196(3):747-54. PubMed ID: 26968644
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis.
    Pinto R; Lopes T; Frias B; Silva A; Silva JA; Silva CM; Cruz C; Cruz F; Dinis P
    Eur Urol; 2010 Sep; 58(3):360-5. PubMed ID: 20227820
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The urodynamic characteristics and prognostic factors of patients with interstitial cystitis/bladder pain syndrome.
    Kuo YC; Kuo HC
    Int J Clin Pract; 2013 Sep; 67(9):863-9. PubMed ID: 23952465
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis.
    Chiu B; Tai HC; Chung SD; Birder LA
    Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27376330
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of non-ablative vaginal erbium:YAG laser treatment for interstitial cystitis/bladder pain syndrome: a case series (UNICORN-2 study).
    Okui N; Okui M; Vizintin Z
    Climacteric; 2020; 23(sup1):S14-S17. PubMed ID: 33124452
    [No Abstract]   [Full Text] [Related]  

  • 56. Reliability and validity of Turkish versions of the interstitial cystitis symptom index and interstitial cystitis problem index.
    Esen B; Obaid K; Süer E; Gökçe Mİ; Gökmen D; Bedük Y; Gülpınar Ö
    Neurourol Urodyn; 2020 Nov; 39(8):2338-2343. PubMed ID: 32846036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of botulinum toxin injection for interstitial cystitis/bladder pain syndrome: a systematic review and meta-analysis.
    Shim SR; Cho YJ; Shin IS; Kim JH
    Int Urol Nephrol; 2016 Aug; 48(8):1215-1227. PubMed ID: 27139498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hydrodistension plus Onabotulinumtoxin A in bladder pain syndrome refractory to conservative treatments.
    Lorenzo L; Bonillo MA; Arlandis S; Martínez-Cuenca E; Marzullo L; Broseta E; Boronat F
    Actas Urol Esp; 2016 Jun; 40(5):303-8. PubMed ID: 26877071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anxiety severity does not influence treatment outcomes in patients with interstitial cystitis/bladder pain syndrome.
    Yu WR; Peng TC; Yeh HL; Kuo HC
    Neurourol Urodyn; 2019 Aug; 38(6):1602-1610. PubMed ID: 31059599
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bladder instillations vs onabotulinumtoxinA injection for interstitial cystitis/bladder pain syndrome: a randomized clinical trial.
    Welch EK; Dengler KL; DiCarlo-Meacham AM; Wheat JE; Pekny CJ; Aden JK; Vaccaro CM
    Am J Obstet Gynecol; 2024 May; ():. PubMed ID: 38768800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.